2015
DOI: 10.1016/j.ihj.2015.07.033
|View full text |Cite
|
Sign up to set email alerts
|

Calcific aortic valve disease: Is it another face of atherosclerosis?

Abstract: Calcific aortic valve disease (CAVD) is the most common valvular heart disease in the elderly. As life expectancy increases, prevalence of CAVD is expected to rise. CAVD is characterized by progressive dystrophic calcification of aortic cusps. In the initial stages, the pathogenesis is similar to atherosclerosis, characterized by basement membrane disruption, inflammation, cell infiltration, lipid deposition, and calcification. Presence of osteopontin in calcified aortic valves suggests pathological calcificat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
1
4

Year Published

2016
2016
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 42 publications
(33 citation statements)
references
References 24 publications
0
28
1
4
Order By: Relevance
“…Although disrupted lipid metabolism and deposition contribute to the development of atherosclerosis and although CAVD resembles atherosclerosis in many ways (Sathyamurthy and Alex 2015), in the present work, neither GO terms nor KEGG pathways related to lipid metabolism were among the top-ranked lists in human samples. Moreover, statins (inhibitors of HMG Co-A reductase and reduces low-density lipoprotein cholesterol) have been shown to be unable to halt the progression of CAVD in recent randomized clinical trials (Chan et al 2010).…”
Section: Modulecontrasting
confidence: 64%
“…Although disrupted lipid metabolism and deposition contribute to the development of atherosclerosis and although CAVD resembles atherosclerosis in many ways (Sathyamurthy and Alex 2015), in the present work, neither GO terms nor KEGG pathways related to lipid metabolism were among the top-ranked lists in human samples. Moreover, statins (inhibitors of HMG Co-A reductase and reduces low-density lipoprotein cholesterol) have been shown to be unable to halt the progression of CAVD in recent randomized clinical trials (Chan et al 2010).…”
Section: Modulecontrasting
confidence: 64%
“…Autopsy studies have confirmed an association between coronary artery calcification and cardiac VC, suggesting that VC is a marker of atherosclerosis [3]. The pathophysiology of VC is also an active process akin to atherosclerosis and involves initiating factors, endothelial dysfunction, inflammatory responses, oxidative stress leading to remodeling and mineralization of valves [19, 20]. However, the molecular and cellular processes that contribute to VC are not fully characterized.…”
Section: Discussionmentioning
confidence: 99%
“…However, emerging evidence has indicated that this condition is mediated by the interplay of complex biological processes that include the following: inflammation, cell apoptosis, lipids deposition, renin-angiotensin system activation, remodeling of the extracellular matrix, and bone formation [411]. However, the underlying mechanisms that regulate this process remain largely unknown [12, 13]. …”
Section: Introductionmentioning
confidence: 99%